Coya is currently conducting the ALSTARS Trial, a Phase 2, randomized, multi-center, double-blind, placebo-controlled study to evaluate the efficacy and safety of COYA 302 for the treatment of ALS ( ...
Company to share additional CLYM116 clinical data and plans for further development at R&D Spotlight in late summer ...
To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min The club's closure comes as ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results